Jefferies Financial Group reiterated their restricted rating on shares of Johnson Matthey (LON:JMAT – Free Report) in a research report released on Friday morning, MarketBeat reports.
Several other brokerages have also recently weighed in on JMAT. Berenberg Bank reduced their price target on Johnson Matthey from GBX 2,250 to GBX 2,100 and set a “buy” rating on the stock in a research note on Monday, March 23rd. UBS Group reissued a “neutral” rating and issued a GBX 2,200 target price on shares of Johnson Matthey in a research note on Friday, May 22nd. Finally, Deutsche Bank Aktiengesellschaft increased their target price on Johnson Matthey from GBX 1,922 to GBX 2,120 and gave the stock a “buy” rating in a research note on Tuesday, April 7th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, Johnson Matthey currently has an average rating of “Moderate Buy” and an average target price of GBX 2,265.
Get Our Latest Stock Report on Johnson Matthey
Johnson Matthey Stock Performance
Johnson Matthey (LON:JMAT – Get Free Report) last posted its earnings results on Thursday, May 28th. The company reported GBX 128.50 earnings per share (EPS) for the quarter. Johnson Matthey had a negative return on equity of 4.66% and a negative net margin of 0.76%.The firm had revenue of GBX 1,257.30 billion for the quarter. As a group, equities analysts anticipate that Johnson Matthey will post 173.4112903 EPS for the current year.
Insider Transactions at Johnson Matthey
In related news, insider Liam Condon acquired 14 shares of the firm’s stock in a transaction dated Wednesday, March 11th. The shares were purchased at an average price of GBX 1,941 per share, with a total value of £271.74. Also, insider Alastair Judge acquired 14 shares of the firm’s stock in a transaction dated Wednesday, April 15th. The stock was bought at an average cost of GBX 2,022 per share, for a total transaction of £283.08. In the last three months, insiders acquired 72 shares of company stock worth $146,198. 0.51% of the stock is owned by corporate insiders.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Featured Articles
- Five stocks we like better than Johnson Matthey
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
